Dr. Gerald Diaz @GeraldMD
48.6M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
7 results
dm2 pharmacology diagnosis antidiabetic comparison decisionaid delirium diabetic dosing dpp4 eudka euglycemic inhibitors ketoacidosis micu oral orals pancreatitis profiles renal
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 #Diabetes ... #Endocrinology ... #Pharmacology #Management
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... #comparison #management ... #endocrinology
Pancreatitis management checklist Evaluation to guide etiology & management - RUQ ultrasound - Calcium
checklist Evaluation ... - Review of medication ... potentially causative drugs ... limit them as able ... #CriticalCare
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
thing about this drug ... This drug class ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Euglycemic Diabetic ... Inhibitors Increasing Indications ... Significant Adverse Drug ... EuDKA #diagnosis #management ... #endocrinology
Checklist for Treatment of Delirium in the ICU Remove causative factors - Exclude hypoglycemia if
Checklist for Treatment ... - Review the medication ... c deliriogenic meds ... #Management #Treatment ... #MICU #CriticalCare
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... to remain stable ... patients to take meds ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology
empty